维普期刊资源整合服务平台（V6.5）

61篇 您的检索式：作者名="Dickler"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	A phase Ⅱ trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer显示文摘	Dickler MN Rugo HS Eberle CA	2008	Clin Cancer Res2008，14，：	1
2	Phase Ⅱ trial of erlotinib ( OSI-774), an epidermal growth factor receptor ( EGFR ) -Wrosine kinase inhibitor, and bevacizumab, a recombinant humanized monoclonal antibody to vascular endothelial growth factor- VEGF) ,in patients ( pts ) with metastatic brast cancer ( MBC ) 显示文摘	Dickler M Rugo H CaraveUi J	2004	Proc Am Soc Clin Oneol2004，23，：	1
3	Maximizing the potential of bevacizumab in cancer treatment显示文摘	Bergsland E Dickler MN	2004	Oncologist2004，9，1：	1
4	Identification of an alternative CTLA-4 ligand cnstimulatory for T cell activation显示文摘	Hathcock KS Laszlo G Dickler HB	1993	Science1993，262，5135：	1
5	Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer显示文摘	Dickler MN Cobleigh MA Miller KD	2009	Breast Cancer Res Treat2009，115，1：	1
6	Living with metastatic breast cancer: a qualitativeanalysis of physical, psy- chological, and social sequelae 显示文摘	Mosher CE Johnson CM Dickler M	2013	Breast J2013，19，3：	1
7	Immunogenicity of a fu-cosyl-GM1 -keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer显示文摘	Dickler MN Ragupathi G Liu NX	1999	Clin Cancer Res1999，5，10：	1
8	Identification of an altematire CTLA4 ligend costimulatory for T cell activation显示文摘	Hathcock K S Laszlo G Dickler H B	1993	Science1993，262，5135：	1
9	Treatment volume and dose optimization of MammoSite breast brachytherapy applicator显示文摘	Dickler A Kirk M Choo J	2004	Int J Radiat Oncol Biol Phys2004，59，2：	1
10	Maximizing the potential of Bevacizumab in cancer treatment显示文摘	Bergsland E Dickler MN	2004	Oncologist2004，9，1：	1
11	Immunization of high-risk breast cancer patients with clustered sTn-KLH conjugate plus the immunologic adjuvant QS-21显示文摘	Gilewski TA Ragupathi G Dickler M	2007	Clin Cancer Res2007，13，：	1
12	Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast canc- er显示文摘	Dickler MN Cobleigh MA Miller KD	2009	Breast Cancer Res Treat2009，115，1：	1
13	A phase II trial of erlotin- ib in combination with bevaeizumab in patients with metastatic breast cancer 显示文摘	Dickler MN Rugo HS Eberle CA	2008	Clin Cancer Res2008，14，23：	1
14	A dosimetric comparison of mammaosite HDR brachytherapy and xoft axxent electronic brachytherapy显示文摘	Dickler A Kirk M Seif N	2007	Brachytherapy2007，6，：	1
15	The role of CDK4/6 inhibition in breast cancer 显示文摘	Murphy CG Dickler MN	2015	Oncologist2015，20，5：	1
16	A dosimetric comparison of mammosite and clearpath HDR brcast brachytherapy devices显示文摘	Dickler A Seif N Kirk M	2007	Int J Radiat Oncol Biol Phys2007，69，：	1
17	Immunogenicityof a fucosyl-GM 1 -keyhole limpet hemocyanin conjugatevaccine in patients with small cell lung cancer 显示文摘	Dickler MN Ragupathi G Liu NX	1999	ClinCancer Res1999，5，10：	1
18	Tomotherapy and Multifield Intensity-Modulated Radiotherapy Planning Reduce Cardiac Doses in Left-Sided Breast Cancer Patients With Unfavorable Cardiac Anatomy显示文摘	Alan B. Coon Adam Dickler Michael C. Kirk Yixiang Liao Anand P. Shah Jonathan B. Strauss Sea Chen Julius Turian Katherine L. Griem	2010	International Journal of Radiation Oncology, Biology, Physics2010，，1：	1
19	Chronic granulomatous disease: Report on a national registry of 368 patients 显示文摘	Winkelstein JA Marino MC Johnston RB Jr Boyle J Curnutte J Gallin JIMalech HL Holland SM Ochs H Quie P Buckley RH Foster CB Chanoek SJ Dickler H	2000	Medicine2000，79，3：	1
20	A phase Ⅱ trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer显示文摘	Dickler MN Rugo HS Eberle CA	2008	Clin Cancer Res2008，14，23：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示